Baxter Theranova: More Middle Molecules, Less Albumin Loss
Baxter’s new dialyzer mimics the function of natural kidneys more closely, removing more middle molecules with no replacement fluid needed—and minimal loss of vital albumin. The new expanded hemodialysis (HDx) therapy has been tested in the UK, where it reduced beta-2 microglobulin levels by more than 11%
Read the full article » | Posted 12-14-2017
Related Articles
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024
- The Public-Private ASN, DHSS, KidneyX Partnership is 5 Years Old This Year Posted 05-09-2024
- New Measure of Home Dialysis Dropout Posted 01-16-2024